Despite their complex nature, one rhodanine is clinically approved for use in nerve damage due to diabetes mellitus (Epalrestat®, an aldose reductase inhibitor)60 and other rhodanine-related heterocycles are in development.61 The gene discussed is AKR1B1; the disease is diabetes mellitus.